These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34822547)

  • 1. Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in
    Szymkowicz L; Gerard J; Messham B; Tam WWV; James DA
    Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a targeted nanoLC-MS/MS method for quantitation of residual toxins from Bordetella pertussis.
    Szymkowicz L; Wilson DJ; James DA
    J Pharm Biomed Anal; 2020 Sep; 188():113395. PubMed ID: 32526622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.
    Gentry-Weeks CR; Cookson BT; Goldman WE; Rimler RB; Porter SB; Curtiss R
    Infect Immun; 1988 Jul; 56(7):1698-707. PubMed ID: 3384473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Teruya S; Hiramatsu Y; Nakamura K; Fukui-Miyazaki A; Tsukamoto K; Shinoda N; Motooka D; Nakamura S; Ishigaki K; Shinzawa N; Nishida T; Sugihara F; Maeda Y; Horiguchi Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics of Bordetella pertussis toxins.
    Antoine R; Raze D; Locht C
    Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
    Scanlon K; Skerry C; Carbonetti N
    Adv Exp Med Biol; 2019; 1183():35-51. PubMed ID: 31376138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of tracheal cytotoxin in pertussis and diphtheria tetanus acellular pertussis vaccines using liquid chromatography-tandem mass spectrometry].
    Long Z; Wei C; Guo Z; Ma X; Li Y; Yao J; Ji F; Li C; Huang T
    Se Pu; 2019 Feb; 37(2):155-161. PubMed ID: 30693723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis tracheal cytotoxin.
    Goldman WE; Herwaldt LA
    Dev Biol Stand; 1985; 61():103-11. PubMed ID: 2872096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for a new acellular pertussis vaccine.
    Manclark CR; Burns DL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):323-9. PubMed ID: 2870676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence factors of Bordetella pertussis.
    Mooi FR
    Antonie Van Leeuwenhoek; 1988; 54(5):465-74. PubMed ID: 2904800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenylate cyclase toxin (ACT) from Bordetella hinzii: characterization and differences from ACT of Bordetella pertussis.
    Donato GM; Hsia HL; Green CS; Hewlett EL
    J Bacteriol; 2005 Nov; 187(22):7579-88. PubMed ID: 16267282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.
    Khelef N; Bachelet CM; Vargaftig BB; Guiso N
    Infect Immun; 1994 Jul; 62(7):2893-900. PubMed ID: 7999145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the dermonecrotic toxin in members of the genus Bordetella.
    Walker KE; Weiss AA
    Infect Immun; 1994 Sep; 62(9):3817-28. PubMed ID: 8063398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9.
    Havlícek V; Higgins L; Chen W; Halada P; Sebo P; Sakamoto H; Hackett M
    J Mass Spectrom; 2001 Apr; 36(4):384-91. PubMed ID: 11333441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
    Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative structural and immunological analysis of outer membrane proteins and dermonecrotic toxin in Bordetella bronchiseptica canine isolate.
    Jang JY; Oh MW; Na C; Im YB; Shim S; Moon HJ; Yoo HS
    Vet Immunol Immunopathol; 2024 Jun; 272():110756. PubMed ID: 38657357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin.
    Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R
    Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.
    Pearson RD; Symes P; Conboy M; Weiss AA; Hewlett EL
    J Immunol; 1987 Oct; 139(8):2749-54. PubMed ID: 2888823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.
    Khelef N; Danve B; Quentin-Millet MJ; Guiso N
    Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.